The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Spondylarthropathies


High impact information on Spondylarthropathies


Chemical compound and disease context of Spondylarthropathies


Biological context of Spondylarthropathies


Anatomical context of Spondylarthropathies


Gene context of Spondylarthropathies


Analytical, diagnostic and therapeutic context of Spondylarthropathies


  1. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Hermann, E., Yu, D.T., Meyer zum Büschenfelde, K.H., Fleischer, B. Lancet (1993) [Pubmed]
  2. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Matsumoto, I., Lee, D.M., Goldbach-Mansky, R., Sumida, T., Hitchon, C.A., Schur, P.H., Anderson, R.J., Coblyn, J.S., Weinblatt, M.E., Brenner, M., Duclos, B., Pasquali, J.L., El-Gabalawy, H., Mathis, D., Benoist, C. Arthritis Rheum. (2003) [Pubmed]
  3. Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy. Olivieri, I., Costa, A.M., Cantini, F., Niccoli, L., Marini, R., Ferri, S. Arthritis Rheum. (1996) [Pubmed]
  4. Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Kuntz, D., Naveau, B., Bardin, T., Drueke, T., Treves, R., Dryll, A. Arthritis Rheum. (1984) [Pubmed]
  5. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Kruithof, E., De Rycke, L., Roth, J., Mielants, H., Van den Bosch, F., De Keyser, F., Veys, E.M., Baeten, D. Arthritis Rheum. (2005) [Pubmed]
  6. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Bjarnason, I., Helgason, K.O., Geirsson, A.J., Sigthorsson, G., Reynisdottir, I., Gudbjartsson, D., Einarsdottir, A.S., Sherwood, R., Kristjansson, K., Kjartansson, O., Thjodleifsson, B. Gastroenterology (2003) [Pubmed]
  7. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. De Rycke, L., Vandooren, B., Kruithof, E., De Keyser, F., Veys, E.M., Baeten, D. Arthritis Rheum. (2005) [Pubmed]
  8. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. De Rycke, L., Baeten, D., Kruithof, E., Van den Bosch, F., Veys, E.M., De Keyser, F. Arthritis Rheum. (2005) [Pubmed]
  9. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Dougados, M., vam der Linden, S., Leirisalo-Repo, M., Huitfeldt, B., Juhlin, R., Veys, E., Zeidler, H., Kvien, T.K., Olivieri, I., Dijkmans, B. Arthritis Rheum. (1995) [Pubmed]
  10. The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al. Lee, L., Lawford, R., McNeil, H.P. Arthritis Rheum. (2001) [Pubmed]
  11. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Huet, G., Flipo, R.M., Richet, C., Thiebaut, C., Demeyer, D., Balduyck, M., Duquesnoy, B., Degand, P. Clin. Chem. (1992) [Pubmed]
  12. Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Luukkainen, R., Nissilä, M., Asikainen, E., Sanila, M., Lehtinen, K., Alanaatu, A., Kautiainen, H. Clinical and experimental rheumatology. (1999) [Pubmed]
  13. Aggressive treatment in childhood rheumatic diseases. Schaller, J.G. Clinical and experimental rheumatology. (1994) [Pubmed]
  14. Association of HLA alleles and clinical features in patients with synovitis of recent onset. El-Gabalawy, H.S., Goldbach-Mansky, R., Smith, D., Arayssi, T., Bale, S., Gulko, P., Yarboro, C., Wilder, R.L., Klippel, J.H., Schumacher, H.R. Arthritis Rheum. (1999) [Pubmed]
  15. Autosomal dominant spondylarthropathy due to a type II procollagen gene (COL2A1) point mutation. Winterpacht, A., Hilbert, M., Schwarze, U., Mundlos, S., Spranger, J., Zabel, B. Hum. Mutat. (1994) [Pubmed]
  16. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Polgár, A., Falus, A., Koó, E., Ujfalussy, I., Seszták, M., Szuts, I., Konrád, K., Hodinka, L., Bene, E., Mészáros, G., Ortutay, Z., Farkas, E., Paksy, A., Buzás, E.I. Rheumatology (Oxford, England) (2003) [Pubmed]
  17. Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options. Toussirot, E., Wendling, D. Drugs & aging. (2005) [Pubmed]
  18. Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. Djouadi, K., Nedelec, B., Tamouza, R., Genin, E., Ramasawmy, R., Charron, D., Delpech, M., Laoussadi, S. Cytokine (2001) [Pubmed]
  19. Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Brandt, J., Haibel, H., Cornely, D., Golder, W., Gonzalez, J., Reddig, J., Thriene, W., Sieper, J., Braun, J. Arthritis Rheum. (2000) [Pubmed]
  20. HLA-B27-derived peptides as autoantigens for T lymphocytes in ankylosing spondylitis. Märker-Hermann, E., Meyer zum Büschenfelde, K.H., Wildner, G. Arthritis Rheum. (1997) [Pubmed]
  21. Differences in responses of normal and rheumatoid arthritis peripheral blood T cells to synovial fluid and peripheral blood dendritic cells in allogeneic mixed leukocyte reactions. Bergroth, V., Tsai, V., Zvaifler, N.J. Arthritis Rheum. (1989) [Pubmed]
  22. Presence of paf-acether in rheumatic diseases. Hilliquin, P., Menkes, C.J., Laoussadi, S., Benveniste, J., Arnoux, B. Ann. Rheum. Dis. (1992) [Pubmed]
  23. Beta 2 microglobulin-related amyloidosis causing atlantoaxial spondylarthropathy with spinal-cord compression in haemodialysis patients: detection by MRI. Kröner, G., Stäbler, A., Seiderer, M., Moran, J.E., Gurland, H.J. Nephrol. Dial. Transplant. (1991) [Pubmed]
  24. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Cunnane, G., Fitzgerald, O., Beeton, C., Cawston, T.E., Bresnihan, B. Arthritis Rheum. (2001) [Pubmed]
  25. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Cush, J.J., Splawski, J.B., Thomas, R., McFarlin, J.E., Schulze-Koops, H., Davis, L.S., Fujita, K., Lipsky, P.E. Arthritis Rheum. (1995) [Pubmed]
  26. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Drouart, M., Saas, P., Billot, M., Cedoz, J.P., Tiberghien, P., Wendling, D., Toussirot, E. Clin. Exp. Immunol. (2003) [Pubmed]
  27. Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondylarthropathies. Toussirot, E., Lafforgue, P., Boucraut, J., Despieds, P., Schiano, A., Bernard, D., Acquaviva, P.C. Rheumatol. Int. (1994) [Pubmed]
  28. Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies. Shi, S., Ciurli, C., Cartman, A., Pidoux, I., Poole, A.R., Zhang, Y. Arthritis Rheum. (2003) [Pubmed]
  29. Progressive ankylosis in mice. An animal model of spondylarthropathy. I. Clinical and radiographic findings. Mahowald, M.L., Krug, H., Taurog, J. Arthritis Rheum. (1988) [Pubmed]
  30. Gliadin immune reactivity in patients with rheumatoid arthritis. Paimela, L., Kurki, P., Leirisalo-Repo, M., Piirainen, H. Clinical and experimental rheumatology. (1995) [Pubmed]
  31. Complications of axial arthropathies. Westmark, K.D., Weissman, B.N. Orthop. Clin. North Am. (1990) [Pubmed]
  32. HLA B27 and respiratory involvement in axial spondylarthropathies. A retrospective study in 107 male patients. Eulry, F., Mayaudon, H., Sirvin-Bordier, L., Perier, E., Guillemot, C., Lechevalier, D., Magnin, J. Revue du rhumatisme (English ed.) (1998) [Pubmed]
  33. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis. Wijnands, M.J., Van 'T Hof, M.A., Van De Putte, L.B., Van Riel, P.L. Br. J. Rheumatol. (1993) [Pubmed]
WikiGenes - Universities